Reuters: Hot Stocks: Atossa signs breast device deal with McKesson, shares surge

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Easy Facebook Retargeting Bring back lost customers with the #1 Facebook Retargeting platform. Customers get $12 in sales for every $1 they spend. Start a 2-week complimentary trial today. From our sponsors

Atossa signs breast device deal with McKesson, shares surge Sep 18th 2013, 14:47 Sept 18 | Wed Sep 18, 2013 10:47am EDT Sept 18 (Reuters) - Atossa Genetics Inc said an affiliate of U.S. drug wholesaler McKesson Corp would distribute its device used to collect breast fluid for cancer detection. Atossa shares jumped as much as 56 percent in early trading on the Nasdaq. The stock was the top percentage gainer on the exchange. The device, the MASCT system, is used in clinics for non-invasive collection of breast fluid. The fluid is then analyzed at Atossa's unit, the National Reference Laboratory for Breast Health, using the company's Forecyte devices to assess breast cancer risk. Sidoti & Co analyst Jack Wallace said this was good news for Atossa, as the company ties up with a key player. Atossa's stock was up 40 percent at $6.84 on Wednesday morning. (Reporting by Shailesh Kuber; Editing by Kirti Pandey)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions